A new Health Equity track at the annual meeting will guide attendees to important conversations and actionable strategies for providing the best care for patients of color, said CHEST Health Equity Task Force Chair, Nneka Sederstrom, PhD, MPH, MA, FCCP.
Thirty simulation courses during CHEST 2024 will offer practical, hands-on training in the tools and techniques needed to navigate some of pulmonary and critical care medicine’s most chaotic moments.
CHEST 2024 attendees are encouraged to reflect on the stories of their lives outside of medicine and the theme of “My Revolution” during the third annual CHEST After Hours narrative storytelling event.
In addition to being one of the oldest and most historically significant cities in the United States, Boston is home to world-renowned medical centers and education programs and the site of important medical milestones.
Numerous events during the annual meeting will allow members to find their home within CHEST, catch up with attendees who share similar identities and goals, and collaborate on exciting initiatives, said Margaret Pisani, MD, MPH, FCCP.
This year’s CHEST Annual Meeting will provide insight into artificial intelligence in medicine, the health impact of climate change, the vaping epidemic, and more, said CHEST President, Jack D. Buckley, MD, MPH, FCCP.
Longtime CHEST Annual Meeting attendees like Erika D. Lease, MD, FCCP, never tire of connecting with colleagues in person and sharing in the latest scientific and clinical updates.
Robust educational opportunities prior to the annual meeting will help clinicians of all experience levels review foundational knowledge and keep up with changes in the field, said CHEST Education Committee Chair, Hans Lee, MD, MEHP, FCCP.
CHEST President-Elect, John “Jack” D. Buckley, MD, MPH, FCCP, emphasized the importance of mentoring in helping the organization and its clinicians better reflect the diversity of their patients and society.
Fellows from the University of Oklahoma, the University of Southern California, and the University of Texas Health Science Center at Houston competed in creative clinical trivia and live challenges.
Deji Adegunsoye, MD, PhD, FCCP, reviewed the role of genetic testing in pulmonary fibrosis in the past, present, and future management of the disease.
Diego J. Maselli, MD, FCCP, and other experts provided updates on biologics approved in asthma and in trials for COPD.